language_icon
EN
HI

Astal Laboratories Share price

ASTALLTD

72.4

0.94 (1.32%)
Last updated on 1 Jun, 2026 | 15:29 IST
Today's High

76.01

Today's Low

70.00

52 Week Low

60.45

52 Week High

103.20

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Astal Laboratories Chart

Astal Laboratories Share Key Metrics

Volume
33964.00
Market Cap
311.76 CR
LTQ@LTP
101@72.40
ATP
73.89
Var Margin
25 %
Circuit Range
64.32-78.6
Delivery %
81.05 %
Value
25.10 L
ASM/GSM
No
Market Lot
1

Summary

Astal Laboratories share price is ₹72.4 as of 2 Jun, 2026. The stock Astal Laboratories intraday movement has stayed between ₹70.00 and ₹76.01, while on a 52-week basis,Astal Laboratories price 52 week high is ₹103.20 & its 52 week low is ₹60.45.
In terms of trading activity, Astal Laboratories has recorded a volume of 33964 shares, The Astal Laboratories has a market cap of ₹42215632 CR. The stock’s Average Traded Price (ATP) stands at ₹73.89, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 101 @ ₹72.40.
Astal Laboratories operates within a circuit range of ₹64.32 – ₹78.60, with a Value of ₹25.10 L. The Delivery Percentage for the day is 81.05%. Additionally, Astal Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Astal Laboratories Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

69.96

Sector P/B

3.01

Sec. Div. Yield

0.55

Astal Laboratories Resistance and Support

Pivot 72.49

Resistance

First Resistance

74.98

Second Resistance

78.5

Third Resistance

80.99

Support

First Support

68.97

Second Support

66.48

Third Support

62.96

Astal Laboratories Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

4.7%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

95.3%

Others

0%

Total Promoters
MAR '26
4.7%

Astal Laboratories Corporate Actions

DateAgenda
2026-05-30Audited Results
2026-02-14Quarterly Results
2025-11-14Quarterly Results
2025-10-09Preferential issue of shares & Others
2025-08-12Quarterly Results & A.G.M.
2025-05-19Audited Results
2025-01-27Quarterly Results

Astal Laboratories News

Astal Laboratories Ltd - 512600 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 30Th May, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations, 2015.

Astal Laboratories board approved Q4 and FY26 consolidated financial results. Consolidated Q4 revenue increased to ₹13,414.52 Lakhs with net profit at ₹767.99 Lakhs. M/s V R P S & Co. was re-appointed as internal auditors for FY27.
May 30 2026 21:03:20

Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Allotment

Astal Laboratories allotted 1.13 lakh equity shares at Rs. 40 per share to non-promoter warrant holders by converting warrants. This increases the company's paid-up equity capital by 0.26%.
May 26 2026 17:51:47

Astal Laboratories Ltd - 512600 - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 30Th May, 2026.

Astal Laboratories' Board of Directors will meet on May 30, 2026, to consider and approve the audited Q4 FY26 and full-year financial results. The agenda also includes the appointment of an internal auditor for FY27.
May 25 2026 18:03:45

Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Astal Laboratories announced the appointment of M/s. Khedar Ankur & Associates as the new statutory auditors for its material wholly owned subsidiary, Sriven Pharmachem India Private Limited, effective May 19, 2026. This appointment fills a casual vacancy created by the resignation of the previous auditors.
May 20 2026 14:03:10

Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Astal Laboratories received a monitoring agency report confirming no deviation in the utilization of INR 276.87 crore funds from its preferential issue, aimed at acquiring Sriven Pharmachem India Limited to expand its product portfolio.
May 15 2026 17:47:42

Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

Astal Laboratories' material subsidiary, Sriven Pharmachem India Private Limited, announced the resignation of its statutory auditors, M/s. Balaji V & Co. The auditors resigned mid-term, effective May 13, 2026, as they do not possess a mandatory Peer Review Certificate required for auditing material subsidiaries, preventing them from completing the audit for the quarter and financial year ended March 31, 2026.
May 14 2026 12:16:10

Astal Laboratories Ltd - 512600 - Announcement under Regulation 30 (LODR)-Allotment

Astal Laboratories allotted 14.7 lakh equity shares at Rs. 40 each, upon conversion of warrants held by non-promoter investors. This issuance increases the company's paid-up capital by 3.48%.
May 12 2026 18:31:42

Astal Laboratories Ltd - 512600 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May, 2026.

Astal Laboratories allotted 1.47 million equity shares at Rs. 40 per share, totaling Rs. 4.41 crore, through the conversion of warrants. These shares were issued to 11 non-promoter investors.
May 12 2026 17:59:47
Read More

Astal Laboratories Management

NamePosition
Mahendra KumarCompany Secretary & Compliance Officer
Sudheer Karna KankanalaWhole Time Director
View More

Astal Laboratories FAQs

The Buying Price of Astal Laboratories share is 72.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Astal Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astal Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Astal Laboratories shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Astal Laboratories shares is 0. Useful to assess the stock's value relative to its book value.

To assess Astal Laboratories’s valuation compare Sector P/E, P/B which are 69.96 & 3.01 with sector averages, along with growth rates and financial metrics.

The Market Cap of Astal Laboratories is 311.76 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Astal Laboratories share price is 103.20 & 60.45. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Astal Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost